HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aysegul A Sahin Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

8/2002Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
3/2002Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aysegul A Sahin Research Topics

Disease

110Breast Neoplasms (Breast Cancer)
09/2022 - 01/2002
86Neoplasms (Cancer)
09/2022 - 01/2002
21Neoplasm Metastasis (Metastasis)
10/2019 - 05/2002
11Carcinoma (Carcinomatosis)
09/2022 - 01/2002
10Pathologic Complete Response
02/2017 - 06/2005
9Triple Negative Breast Neoplasms
04/2021 - 01/2013
5Carcinogenesis
01/2019 - 08/2002
4Noninfiltrating Intraductal Carcinoma (DCIS)
09/2015 - 06/2002
3Lobular Carcinoma
11/2021 - 01/2002
3Lymphatic Metastasis
10/2018 - 04/2009
3Genetic Predisposition to Disease (Genetic Predisposition)
04/2013 - 02/2002
2Adenocarcinoma
12/2016 - 06/2005
2Brain Neoplasms (Brain Tumor)
05/2015 - 09/2013
2Inflammation (Inflammations)
04/2013 - 08/2007
2Neoplasm Micrometastasis
06/2009 - 09/2003
2Inflammatory Breast Neoplasms
10/2008 - 07/2007
2Margins of Excision
10/2008 - 07/2005
2Disease Progression
11/2004 - 05/2004
1Extramammary Paget Disease (Paget Disease, Extramammary)
05/2019

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
12/2016 - 03/2002
18Estrogen ReceptorsIBA
01/2022 - 04/2002
13Biomarkers (Surrogate Marker)IBA
04/2021 - 06/2002
11Trastuzumab (Herceptin)FDA Link
11/2018 - 08/2003
10Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 04/2002
9Messenger RNA (mRNA)IBA
01/2021 - 03/2002
9Hormones (Hormone)IBA
10/2018 - 01/2004
9Doxorubicin (Adriamycin)FDA LinkGeneric
03/2010 - 06/2002
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2010 - 06/2002
7Fluorouracil (Carac)FDA LinkGeneric
03/2010 - 06/2002
6ErbB Receptors (EGF Receptor)IBA
11/2021 - 05/2003
6human ERBB2 proteinIBA
11/2021 - 06/2005
6LigandsIBA
05/2019 - 03/2002
6Paclitaxel (Taxol)FDA LinkGeneric
03/2015 - 03/2003
5Pharmaceutical PreparationsIBA
12/2018 - 02/2002
5Epidermal Growth Factor (EGF)IBA
12/2018 - 03/2002
5ParaffinIBA
10/2016 - 09/2003
5Estrogens (Estrogen)FDA Link
01/2016 - 03/2002
4Phosphotransferases (Kinase)IBA
04/2021 - 12/2003
4CytokinesIBA
12/2016 - 05/2002
4Cyclin D1IBA
12/2016 - 09/2003
4TamoxifenFDA LinkGeneric
09/2014 - 02/2003
4AnthracyclinesIBA
05/2012 - 06/2002
4Docetaxel (Taxotere)FDA Link
05/2012 - 01/2003
3Phenobarbital (Luminal)FDA Link
09/2022 - 10/2016
3Cyclin EIBA
04/2021 - 01/2016
3Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 10/2002
3Peptides (Polypeptides)IBA
01/2019 - 05/2002
3Formaldehyde (Formol)FDA Link
10/2016 - 09/2003
3Biological ProductsIBA
06/2009 - 10/2002
3Transcription Factors (Transcription Factor)IBA
12/2005 - 08/2003
3NF-kappa B (NF-kB)IBA
12/2005 - 11/2003
3DNA AdductsIBA
09/2003 - 02/2002
2Immune Checkpoint InhibitorsIBA
05/2019 - 01/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2016 - 08/2007
2RNA (Ribonucleic Acid)IBA
09/2015 - 12/2002
2Indicators and Reagents (Reagents)IBA
10/2014 - 01/2004
2Hematoxylin (Haematoxylon)IBA
10/2014 - 04/2005
2Eosine Yellowish-(YS) (Eosin)IBA
10/2014 - 04/2005
2src-Family KinasesIBA
09/2013 - 08/2005
2DNA (Deoxyribonucleic Acid)IBA
04/2013 - 01/2004
2Estrogen Receptor alphaIBA
05/2010 - 03/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2007 - 08/2002
2Epirubicin (Ellence)FDA LinkGeneric
01/2007 - 06/2005
2Protein Glutamine gamma Glutamyltransferase 2IBA
09/2005 - 12/2004
2Complementary DNA (cDNA)IBA
09/2005 - 05/2004
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2005 - 12/2002
2Carrier Proteins (Binding Protein)IBA
11/2003 - 03/2002
2Neuregulin-1 (Neuregulin 1)IBA
05/2003 - 03/2002
2histidine-rich proteinsIBA
05/2003 - 03/2002
2CarcinogensIBA
08/2002 - 02/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2002 - 03/2002
1Granzymes (Granzyme)IBA
01/2022
1Cytotoxins (Cytolysins)IBA
09/2021
1dinutuximabIBA
01/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2019
1Nucleic AcidsIBA
01/2019
1safingol (sphinganine)IBA
01/2019
1Long Noncoding RNAIBA
01/2019
1Ligases (Synthetase)IBA
01/2019
1sphingosine kinaseIBA
01/2019
1Histones (Histone)IBA
01/2019
1AntigensIBA
01/2019
1Bortezomib (Velcade)FDA Link
01/2019
1Programmed Cell Death 1 ReceptorIBA
12/2018
1TransferasesIBA
12/2018
1B7-H1 AntigenIBA
12/2018
1N-acetyltalosaminuronic acid (NAT)IBA
11/2018
1CurcuminIBA
12/2016
1Lactoglobulins (beta-Lactoglobulin)FDA Link
12/2016
1Aurora Kinase AIBA
12/2016
1Biological FactorsIBA
07/2016

Therapy/Procedure

34Therapeutics
09/2021 - 10/2002
27Neoadjuvant Therapy
11/2021 - 06/2002
24Drug Therapy (Chemotherapy)
01/2021 - 06/2002
10Radiotherapy
10/2018 - 07/2002
6Segmental Mastectomy (Lumpectomy)
06/2019 - 09/2003
6Mastectomy (Mammectomy)
01/2013 - 07/2002
3Adjuvant Chemotherapy
03/2010 - 07/2002
2Aftercare (After-Treatment)
07/2016 - 11/2002
1Immunotherapy
01/2019